| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Hubert H. Humphrey Cancer Center, Boston University School of Medicine, Boston, Massachusetts 02118
Retinoic acid inhibits the proliferation of B16 mouse melanoma cells. It also eliminates the ability of these cells to grow in soft agar. These biological actions of retinoic acid have been shown to be accompanied by an increase in the amount of cyclic AMP-dependent protein kinase and an induction of a new isozyme form (RII ß). In this report we demonstrated that retinoic acid-treated B16 melanoma cells had large increases in protein kinase C activity.
This increased enzyme activity was accompanied by increases in both the number of phorbol dibutyrate binding sites and the amount of immunoreactive protein kinase C. Other treatments (melanocyte-stimulating hormone, serum deprivation) which inhibited the growth of these cells did not increase protein kinase C activity. When B16 melanoma cells were treated for a prolonged time (72 h) with phorbol dibutyrate, protein kinase C activity was barely detectable. Under these conditions, melanin production was inhibited and cell growth was accelerated. When retinoic acid was added together with phorbol dibutyrate, it prevented the growth stimulatory effect of the phorbol ester and increased protein kinase C activity. However, the absolute activity of the enzyme was still below that found in control cells and very much lower than in cells treated with retinoic acid alone. Taken together with our previous findings, we propose that the increase in protein kinase C might be part of a differentiation program induced by retinoic acid.
1 This work was supported in part by a grant from the American Institute for Cancer Research.
2 To whom requests for reprints should be addressed.
Received 9/19/88. Revised 5/ 1/89. Accepted 5/ 9/89.
This article has been cited by other articles:
![]() |
R. M. Niles Vitamin A (Retinoids) Regulation of Mouse Melanoma Growth and Differentiation J. Nutr., January 1, 2003; 133(1): 282S - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boskovic, D. Desai, and R. M. Niles Regulation of Retinoic Acid Receptor alpha by Protein Kinase C in B16 Mouse Melanoma Cells J. Biol. Chem., July 12, 2002; 277(29): 26113 - 26119. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, T. Murata, S. Ohno, N. Day, J. Song, N. Nomura, T. Nakahara, and K. K. Yokoyama Protein Kinase Calpha Plays a Critical Role in Mannosylerythritol Lipid-induced Differentiation of Melanoma B16 Cells J. Biol. Chem., October 19, 2001; 276(43): 39903 - 39910. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Rusciano, P Lorenzoni, and M. Burger Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone J. Cell Sci., January 3, 1999; 112(5): 623 - 630. [Abstract] [PDF] |
||||
![]() |
S. H. Desai and R. M. Niles Characterization of Retinoic Acid-induced AP-1 Activity in B16 Mouse Melanoma Cells J. Biol. Chem., May 9, 1997; 272(19): 12809 - 12815. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Romero, E Aberdam, C Larnier, and J. Ortonne Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression J. Cell Sci., January 4, 1994; 107(4): 1095 - 1103. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |